Compare VERA & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | TRMK |
|---|---|---|
| Founded | 2016 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | 2021 | 1994 |
| Metric | VERA | TRMK |
|---|---|---|
| Price | $33.62 | $47.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $81.30 | $44.50 |
| AVG Volume (30 Days) | ★ 2.1M | 286.6K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.26% |
| EPS Growth | N/A | ★ 1.93 |
| EPS | N/A | ★ 2.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.82 |
| Revenue Next Year | $472.48 | $4.86 |
| P/E Ratio | ★ N/A | $23.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.05 | $36.33 |
| 52 Week High | $56.05 | $49.00 |
| Indicator | VERA | TRMK |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 54.22 |
| Support Level | $33.43 | $46.77 |
| Resistance Level | $36.89 | $47.72 |
| Average True Range (ATR) | 1.61 | 0.84 |
| MACD | 0.08 | 0.11 |
| Stochastic Oscillator | 28.68 | 72.49 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.